...
首页> 外文期刊>Medicine. >Intestinal fatty acid-binding protein as a predictor of prognosis in postoperative cardiac surgery patients
【24h】

Intestinal fatty acid-binding protein as a predictor of prognosis in postoperative cardiac surgery patients

机译:肠脂肪酸结合蛋白可作为心脏手术后患者预后的指标

获取原文
   

获取外文期刊封面封底 >>

       

摘要

During the perioperative period of cardiac disease, as many risk factors exist, such as primary cardiac diseases, the use of vasopressors, ischemia-reperfusion injury during cardiopulmonary bypass (CPB), and surgical stress, the gut suffered from ischemia, anoxia and oxidative stress, which would lead to the enterocyte injury. The aim of this study was to explore whether serum intestinal fatty acid-binding protein (IFABP), which is excreted specifically from damaged intestinal enterocytes, as a predictor of prognosis in postoperative cardiac surgery patients. From January 2017 to December 2017, 40 postoperative cardiac surgery patients were enrolled in this observational study. Serum IFABP levels and prognostic biomarkers were recorded at intensive care unit (ICU) admission. The serum IFABP levels were significantly higher in postoperative cardiac surgery patients who complicated with multiple organ dysfunction syndrome (MODS) (median, 883.20 pg/mL vs 426.10 pg/mL; P < .001), infective complications (median, 917.70 pg/mL vs 409.40 pg/mL; P < .001), or who stayed in ICU beyond 4 days (median, 807.65 pg/mL vs 426.10 pg/mL; P < .001). Moreover, in patients who suffered from right ventricular dysfunction, the serum IFABP levels were significantly higher (median, 737.85 pg/mL vs 445.55 pg/mL; P = .016). The serum IFABP levels also showed great precision for the prediction of MODS (the area under curve, AUC 0.923), infective complications (AUC 0.961) and ICU stay beyond 4 days (AUC 0.853). And it correlated significantly with the acute physiology and chronic health evaluation (APACHE) II score ( P < .05), sequential organ failure assessment (SOFA) score ( P < .05), and acute gastrointestinal injury (AGI) grade ( P < .001). The serum IFABP level at ICU admission is a valuable, convenient, and objective early predictor of prognosis in postoperative cardiac surgery patients.
机译:在心脏病的围手术期中,存在许多危险因素,例如原发性心脏病,使用升压药,体外循环(CPB)期间的缺血再灌注损伤和手术压力,肠道遭受缺血,缺氧和氧化应激,这将导致肠细胞损伤。这项研究的目的是探讨是否从受损肠肠上皮细胞中特异性分泌的血清肠脂肪酸结合蛋白(IFABP)作为心脏手术后患者预后的预测指标。从2017年1月到2017年12月,该观察性研究招募了40名术后心脏手术患者。重症监护病房(ICU)入院时记录血清IFABP水平和预后生物标志物。患有多器官功能障碍综合症(MODS)的术后心脏手术患者的血清IFABP水平显着升高(中位数883.20 pg / mL vs 426.10 pg / mL; P <.001),感染性并发症(中位数917.70 pg / mL) vs 409.40 pg / mL; P <.001),或在ICU中停留超过4天的患者(中位数为807.65 pg / mL vs 426.10 pg / mL; P <.001)。此外,在患有右心室功能障碍的患者中,血清IFABP水平显着更高(中位数为737.85 pg / mL对445.55 pg / mL; P = .016)。血清IFABP水平也显示出非常高的预测MODS(曲线下面积,AUC 0.923),感染并发症(AUC 0.961)和ICU停留超过4天(AUC 0.853)的精确度。并且它与急性生理和慢性健康评估(APACHE)II评分(P <.05),顺序器官衰竭评估(SOFA)评分(P <.05)和急性胃肠道损伤(AGI)等级(P < .001)。 ICU入院时血清IFABP水平是术后心脏手术患者预后的有价值,方便和客观的早期预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号